Pfizer Limited (NSE:PFIZER)

Market Cap	231.23B
Revenue (ttm)	22.81B
Net Income (ttm)	7.68B
Shares Out	45.75M
EPS (ttm)	167.79
PE Ratio	30.12
Forward PE	33.91
Dividend	35.00 (0.67%)
Ex-Dividend Date	Jul 9, 2025

Volume	14,800
Average Volume	30,345
Open	5,246.00
Previous Close	5,194.50
Day's Range	5,025.00 - 5,246.00
52-Week Range	3,701.00 - 6,451.15
Beta	0.13
RSI	27.49
Earnings Date	Aug 14, 2025

About Triumph Group

Pfizer Limited engages in manufacturing, marketing, trading, and distribution of pharmaceutical products in India and internationally. It offers its products in various therapeutic areas, including neuro/CNS, hormones, cardiovascular, haemophilia, anti-infectives, gynecology, pain/analgesics, orthopedic, oncology, urology, anti-parasitic, gastrointestinal, vaccines, and respiratory, as well as vitamins, minerals, and nutrients. The company also offers anti-infectives services to hospitals and nursing homes. It sells its products through a netwo...

• Industry: Drug Manufacturers - General
• Sector: Healthcare
• Founded: 1950
• Employees: 1,598
• Stock Exchange: National Stock Exchange of India
• Ticker Symbol: PFIZER

Financial Performance

In 2024, Pfizer's revenue was 22.81 billion, an increase of 4.02% compared to the previous year's 21.93 billion. Earnings were 7.68 billion, an increase of 39.23%.